Crestline Management’s Esperion Therapeutics ESPR Stock Holding History

Crestline Management’s Portfolio ESPR Stock Details ESPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell
2024 Q4	$63.2K	Buy
2018 Q3	–	Sell
2018 Q2	$1.73M	Buy
2017 Q4	–	Sell
2017 Q3	$1.32M	Sell
2017 Q2	$1.9M	Buy
2017 Q1	$967K	Buy